Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-29 · accession 0001628280-24-025999 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-31 | 2024-05-29 | VIR | Farid Ramy | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
| DM | 2024-05-31 | 2024-05-29 | VIR | Farid Ramy | Dir | A - Grant | $0.00 | +32.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | A | A | 16,000 | $0.00 | 16,000 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-05-29 | A | A | 16,000 | $0.00 | 16,000 | D | $10.10 · — to 2034-05-28 | 16,000 Common Stock | (F2) Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-29 | A | A | 16,000 | $0.00 | 16,000 | D | $10.10 · — to 2034-05-28 | 16,000 Common Stock | (F1) 1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter. |